November Talcum Powder Lawsuit Filed In Georgia

A woman in Georgia filed a talcum powder cancer lawsuit against Johnson & Johnson claiming the company contributed to her 2015 ovarian cancer diagnosis.

Wednesday, November 16, 2016 - A new talcum powder ovarian cancer lawsuit was filed in southern Georgia on November 1 claiming Johnson & Johnson holds responsibility for the role their popular cosmetic played in the ovarian cancer diagnosis of the plaintiff. The baby powder lawsuit claims that not only did Johnson & Johnson knowingly market their product as safe while aware of its carcinogenic properties, but that the company was also aware of alternative products that could have been used by consumers that held no association with an increased risk of ovarian cancer.

The Georgia talcum powder cancer lawsuit was filed in the Savannah District of the Southern District of Georgia federal court. Baby powder attorneys are representing plaintiff Mary Young in the claim, a woman who was diagnosed with ovarian cancer after roughly 20 years of using talcum powder to maintain genital hygiene. This method of talcum powder use has been found in more than 20 medical studies to correlate with an increased risk for ovarian cancer. Young's talcum powder ovarian cancer lawyers claim that Johnson & Johnson were aware of these studies and continued to market the product and its particular use as a genital hygienic to women as safe.

The Johnson & Johnson's baby powder cancer lawsuit also notes that throughout the entire period that Young used talcum powder, there were cornstarch-based alternatives that would have served the same purpose and held no connection to ovarian cancer. Young's baby powder attorneys claim Johnson & Johnson were aware of both the medical studies that had been conducted into the cancer-causing properties of talcum powder and the existence of safe alternatives and made no effort to warn consumers or apply warning labels to their products.

Instead of warning consumers, the talcum powder cancer lawsuit claims that Johnson & Johnson actively marketed the cosmetic for use in the precise way studies had shown it to be linked to ovarian cancer. Taglines such as "A sprinkle a day keeps odor away," and "Your body perspires in more places than just under your arms. Use SHOWER to SHOWER to

feel dry, fresh, and comfortable throughout the day," were quoted in the lawsuit to exemplify how Johnson & Johnson had encouraged the use of their product.

Talcum powder attorneys throughout the country have also been referencing internal documents recovered from Johnson & Johnson proving the company was made aware of the connection between talcum powder and ovarian cancer as early as the 1990's. Doctors working with Johnson & Johnson alerted company management of the medical studies looking into the connection between talcum powder and ovarian cancer and warned them about the consequences of not affixing warning labels to their products if the findings continually pointed towards a carcinogenic link. In the decades that have passed since those internal documents, plaintiffs have claimed Johnson & Johnson have not taken the necessary steps to protect consumers from ovarian cancer and hold responsibility for their actions contributing to thousands of women contracting the disease.

According to Fortune Magazine, there are currently upwards of 2,000 Johnson & Johnson's baby powder lawsuits currently pending around the nation. Three of those baby powder lawsuits went to trial in 2016, with the plaintiffs winning each and combining for roughly $195 million in damages from Johnson & Johnson.

Information provided by TalcumPowderCancerLawsuit.com, a website devoted to providing news about talcum powder ovarian cancer lawsuits, as well as medical research and findings.